You are on page 1of 15

Renub Research

www.renub.com
Canada Pediatric Vaccines Market, Doses,
Immunization (Vaccinated), Cases & Forecast

Published: April, 2015


Renub Research

Page 1 of 15

Copyright 2015 Renub Research All Rights Reserved

Canada Pediatric Vaccines Market Analysis


Pediatric vaccines market continues to be the success story for the manufacturers of pediatric
vaccines in Canada. The value of the Canada pediatric vaccines market is expected to be
slightly less than US$ 2 Billion by 2020. Pneumococcal vaccines (PCV) and Varicella vaccines
are the leading market share holder in Canada and together they contribute more than 50% of
the total Pediatric vaccines market.

Polio, Measles, Mumps & Rubella (MMR), Diphtheria,

Tetanus & Pertussis (DTaP) cases have shown diminishing trends from the year 2001 till 2013.
On

the

contrary,

in

terms

of

Doses,

Diphtheria,

Tetanus

& Pertussis(DTaP)

and

Pneumococcal vaccines (PCV) have the highest number of doses in 2014.Diphtheria, Tetanus &
Pertussis(DTap) and Polio are the highly penetrated vaccines in Canada pediatric vaccines
market in 2014. It is predicted that these two vaccines will bolster the usable pattern in
Canada. Canada Pediatric vaccines are expected to remain highly active in the future, fueled
by the encouragement and financing from Governments and other health organizations. Canada
Pediatric vaccines market is driven by favorable demographics, growing public acceptance and
product innovation.
This is Renub Research 7th edition report on Vaccines Market & 2nd edition on Pediatric
Vaccines Sector. Report titled "Canada Pediatric Vaccines Market, Doses, Immunization
(Vaccinated), Cases & Forecast talks about the pediatric vaccines scenario in Canada. This
report provides information on Eight (8) segments of Pediatric Vaccines Market, Pediatric
Vaccines Doses, Pediatric Vaccines number of Children Being Vaccinated and Number of Cases
in Canada. This report covers in detail all aspects of Past, Present and Future Scenario. The
report also entails major factors driving the Pediatric Vaccines Market and Challenges of
Canada Pediatric Vaccines Market.
8 Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
Renub Research

Page 2 of 15

6. Hepatitis B Pediatric Vaccines


7. Varicella / Chicken Pox Vaccines
8. Meningococcal C Conjugate (MenC) Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:

Number of Cases

Number of Doses

Number of Children Being Vaccinated

Market Size for all 8 Pediatric Vaccines

Data Sources

This report is built using data and information sourced from proprietary databases, primary and
secondary research and inhouse analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non
printable sources like search engines, News websites, Government websites, Trade Journals,
White Papers, Government Agencies, Magazines, Newspapers, Trade Associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.

Renub Research

Page 3 of 15

About Us
Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have longterm experience especially in
international BusinesstoBusiness Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, BioTechnology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in todays ultracompetitive markets.

For more information on us or to view any of our sample work you can mail
us at info@renub.com

Renub Research

Page 4 of 15

Published
By

Renub Research
A116B, Sector27
Noida 201301
Phone: +911204219822, 2545750 (India)
+16783020700 (USA)
Fax : +911204249780
Email: info@renub.com
Website: www.renub.com

Canada Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
Renub Research, 2015
Edition 2.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

Renub Research

Page 5 of 15

Table of Contents
1.

Executive Summary

2.

Canada Pediatric Vaccines Market & Forecast

3.

Canada Pediatric Vaccines Market Share & Forecast

4.

Canada Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast
4.1

Canada Measles, Mumps & Rubella (MMR) Vaccines & Forecast

4.1.1

Number of Measles, Mumps & Rubella (MMR) Cases

4.1.2

Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

4.1.3

Measles, Mumps & Rubella (MMR) Number of Children Being Vaccinated

4.1.4

Market Size of Measles, Mumps & Rubella (MMR) Vaccines

4.2

Canada Haemophilus Influenzae Type B (HIB) Vaccines & Forecast

4.2.1

Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

4.2.2

Haemophilus Influenzae Type B (HIB) Number of Children Being Vaccinated

4.2.3

Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

4.3

Canada Polio Vaccines & Forecast

4.3.1

Number of Polio Cases

4.3.2

Number of Polio Vaccines Doses

4.3.3

Polio Vaccines Number of Children Being Vaccinated

4.3.4

Market Size of Polio Vaccines

4.4

Canada Diphtheria, Tetanus & Pertussis (DTaP) Vaccines & Forecast

4.4.1

Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases

4.4.2

Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses

4.4.3

Diphtheria, Tetanus & Pertusis (DTaP) Number of Children Being Vaccinated

4.4.4

Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines

4.5

Canada Pneumococcal Vaccines & Forecast

4.5.1

Number of Pneumococcal Vaccines Doses

4.5.2

Pneumococcal Number of Children Being Vaccinated

4.5.3

Market Size of Pneumococcal Vaccines

4.6

Canada Hepatitis B Pediatric Vaccines & Forecast

4.6.1

Number of Hepatitis B Pediatric Vaccines Doses

4.6.2

Hepatitis B Pediatric Number of Children Being Vaccinated

4.6.3

Market Size of Hepatitis B Pediatric Vaccines

4.7

Canada Varicella / Chicken Pox Vaccines & Forecast

Renub Research

Page 6 of 15

4.7.1

Number of Varicella / Chicken Pox Vaccines Doses

4.7.2

Varicella / Chicken Pox Number of Children Being Vaccinated

4.7.3

Market Size of Varicella / Chicken Pox Vaccines

4.8

5.

4.8.1

Number of Meningococcal C (MenC) Vaccines Doses

4.8.2

Meningococcal C (MenC) Number of Children Being Vaccinated

4.8.3

Market Size of Meningococcal C (MenC) Vaccines

Growth Drivers of Canada Pediatric Vaccines Market


5.1

6.

Canada Meningococcal C (MenC) Vaccines & Forecast

Immunization & Reduce Preventable Infectious Diseases

5.1.1

Immunization a Collective Protection

5.1.2

Immunization in Public Health Past & Present

5.1.3

Immunizationa Shared Responsibility

5.2

The Vaccine Injury Compensation Program

5.3

Transforming of Vaccine Technologies

5.4

Continuous Focus on Effective Communication Strategies

Challenges of Canada Pediatric Vaccines Market


6.1

Impediment in Pediatric Vaccine Research & Development

6.2

Barriers to New Entrants in the Pediatric Vaccines Market

6.3

Hurdles to Optimal use of Licensed Vaccines

6.3.1

Technical Obstacles

6.3.2

Economic obstacles

6.3.3

Cultural Obstacles

6.4

Complexity of Vaccine Development & Approval System Thwarts Product Development

6.4.1

Legal Obstacles

6.4.2

General Technical Barriers

6.4.3

Economic Barriers

6.4.4

Regulatory Barriers

6.5

Shortening the Timeline for Vaccine Development

Renub Research

Page 7 of 15

List of Figures
Figure 21: Canada Pediatric Vaccines Market (Million US$), 2010 2014
Figure 22: Canada Forecast for Pediatric Vaccines Market (Million US$), 2015 2020
Figure 31: Canada Pediatric Vaccines Market Share (Percent), 2010 2014
Figure 32: Canada Forecast for Pediatric Vaccines Market Share (Percent), 2015 2020
Figure 41: Canada Number of MMR Vaccines Doses (Million Doses), 2010 2014
Figure 42: Canada Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 2020
Figure 43: Canada Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 2014.
......................................................................................................... Error! Bookmark not defined.
Figure 44: United States Forecast for Number of Children Being Vaccinated with MMR Vaccines
(Million), 2015 2020
Figure 45: Canada Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$), 2010 2014
......................................................................................................... Error! Bookmark not defined.
Figure 46: Canada Forecast for Measles, Mumps & Rubella (MMR) Vaccines Market (Million US$),
2015 2020
Figure 47: Canada Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010
2014
Figure 48: Canada Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million
Doses), 2015 2020
Figure 49: Canada Number of Children Being Vaccinated with Haemophilus Influenzae Type B
Vaccines (Million), 2010 2014
Figure 410: Canada Forecast for Number of Children Being Vaccinated with Haemophilus Influenzae
Type B Vaccines (Million), 2015 2020
Figure 411: Canada Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 2014
Figure 412: Canada Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$),
2015 2020
Figure 413: Canada Number of Doses of Polio Vaccines (Million Doses), 2010 2014
Figure 414: Canada Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 2020
......................................................................................................... Error! Bookmark not defined.
Figure 415: Canada Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 2014
......................................................................................................... Error! Bookmark not defined.
Figure 416: Canada Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million),
2015 2020
Figure 417: Canada Polio Vaccines Market (Million US$), 2010 2014
Figure 418: Canada Forecast for Polio Vaccines Market (Million US$), 2015 2020
Figure 419: Canada Number of Doses of DTaP Vaccines (Million Doses), 2010 2014

Renub Research

Page 8 of 15

Figure 420: Canada Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 2020
......................................................................................................... Error! Bookmark not defined.
Figure 421: Canada Number of Children Being Vaccinated with DTaP Vaccines (Million Doses), 2010
2014
Figure 422: Canada Forecast for Number of Children Being Vaccinated with DTap Vaccines (Million
Doses), 2015 2020
Figure 423: Canada Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010
2014
Figure 424: Canada Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million
US$), 2015 2020
Figure 425: Canada Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 2014
Figure 426: Canada Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015
2020
Figure 427: Canada Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010
2014
Figure 428: Canada Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines
(Million), 2015 2020
Figure 429: Canada Pneumococcal Vaccines Market (Million US$), 2010 2014
Figure 430: Canada Forecast for Pneumococcal Vaccines Market (Million US$), 2015 2020
Figure 431: Canada Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 2014
......................................................................................................... Error! Bookmark not defined.
Figure 432: Canada Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses),
2015 2020
Figure 433: Canada Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million),
2010 2014
Figure 434: Canada Forecast for Number of Children Being Vaccinated with Hepatitis B Pediatric
Vaccines (Million), 2015 2020
Figure 435: Canada Hepatitis B Pediatric Vaccines Market (Million US$), 2010 2014
Figure 436: Canada Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 2020
Figure 437: Canada Number of Doses of Varicella Vaccines (Million Doses), 2010 2014
Figure 438: Canada Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 2020
Figure 439: Canada Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010
2014
Figure 440: Canada Forecast for Number of Children Being Vaccinated with Varicella Vaccines
(Million), 2015 2020
Figure 441: Canada Varicella Vaccines Market (Million US$), 2010 2014
Figure 442: Canada Forecast for Varicella Vaccines Market (Million US$), 2015 2020

Renub Research

Page 9 of 15

Figure 443: Canada Number of Doses of Meningococcal C (MenC) Vaccines (Million Doses), 2010
2014
Figure 444: Canada Forecast for Number of Doses of Meningococcal C (MenC) Vaccines (Million
Doses), 2015 2020
Figure 445: Canada Number of Children Being Vaccinated with Meningococcal C (MenC) Vaccines
(Million), 2010 2014
Figure 446: Canada Forecast for Number of Children Being Vaccinated with Meningococcal C (MenC)
Vaccines (Million), 2015 2020
Figure 447: Canada Meningococcal C (MenC) Vaccines Market (Million US$), 2010 2014
Figure 448: Canada Forecast for Meningococcal C (MenC) Vaccines Market (Million US$), 2015
2020

Renub Research

Page 10 of 15

List of Tables
Table 41: Canada Number of Measles Cases (Number), 1999 2013
Table 42: Canada Number of Mumps Cases (Number), 1999 2013
Table 43: Canada Number of Rubella Cases (Number), 1999 2013
Table 44: Canada Number of Polio Cases (Number), 2001 2013
Table 45: Canada Number of Diphtheria Cases (Number), 1999 2013
Table 46: Canada Number of nTetanus Cases (Number), 1999 2013
Table 47: Canada Number of tTetanus Cases (Number), 1999 2013
Table 48: Canada Number of Pertussis Cases (Number), 1999 2013
Table 51: Canada Incidence of Selected Vaccinepreventable Disease, Prevaccine era compared with
Pre-Vaccine Era to 2013
Table 52: Improvement Strategies or Requirements the Joint Commission and the Projects
Collaborating Organizations

Renub Research

Page 11 of 15

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it.
Questions? Please call

+91-120-421-9822 (India),

+1-678-302-0700

(USA)

or

mail

to

info@renub.com

Format
Report Title: Canada Pediatric Vaccines Market, Doses, Immunization
(Vaccinated), Cases & Forecast
Single User
(Email from Publisher)

Hard Copy
(Mail Delivery)

CD Rom
(Mail Delivery)

Global Site License


(Multiple User License)

US$ 1,000

US$ 1,100

US$ 1,100

US$ 1,800

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/canada-pediatric-vaccines-market-doses-immunizationvaccinated-cases-forecast-162
2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=162&pid=1621
To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 12 of 15

Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi 110001
India

Contact Information
First Name:

Last Name:

Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

Renub Research

Page 13 of 15

3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch

Renub Research

Page 14 of 15

Renub Research

Page 15 of 15